Clinical effect of low molecular weight heparin (Fragmin) on DIC : A multicenter cooperative study in Japan
- 30 June 1990
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 59 (1) , 37-49
- https://doi.org/10.1016/0049-3848(90)90269-i
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Substitution of antithrombin III in shock and DIC: A randomized studyThrombosis Research, 1985
- An Objective Assessment of the Interaction of Heparin and Its Fractions with Human PlateletsSeminars in Thrombosis and Hemostasis, 1985
- Rationale Behind the Development of Low Molecular Weight Heparin DerivativesSeminars in Thrombosis and Hemostasis, 1985
- Studies on the Antithrombotic Effects and Pharmacokinetics of Heparin Fractions and FragmentsSeminars in Thrombosis and Hemostasis, 1985
- Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemiaBlood, 1984
- LIVER DYSFUNCTION RATHER THAN INTRAVASCULAR COAGULATION AS THE MAIN CAUSE OF LOW PROTEIN-C AND ANTITHROMBIN-III IN ACUTE-LEUKEMIA1984
- Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapyBlood, 1982
- Minidose heparin therapy. Treatment of chronic intravascular coagulation syndromeArchives of internal medicine (1960), 1980
- ANTITHROMBIN-III TRANSFUSION IN DISSEMINATED INTRAVASCULAR COAGULATIONThe Lancet, 1978